FGFR3 mutations, which are more frequently found in noninvasive bladder cancer than in muscle-invasive cancer, are associated with favorable features and prognosis compared with bladder cancers, showing FGFR3 overexpression only [22,45,46]. This evidence concerns the gene FGFR3 and urinary bladder cancer.